Winter is coming. And that could mean a resurgent Covid-19, particularly the fast spreading Delta variant. These three travel stocks are especially vulnerable to any upsurge in the pandemic. More
Articles
With Progress on Multiple Fronts, Bionano Genomics Stock Is Great Buy Here
Bionano's acquisition of a software company makes Saphyr more attractive, and studies should result in insurers reimbursing those who use the system. BNGO stock is a buy. More
Sundial Growers Stock Is Gearing up for What Could Be a Banner 2022
Sundial is stuck in a trading range, trading as a penny stock, as investors wait for its acquisitions to add meaningfully. More
Expect Further Shiba Inu Price Pull Back as ‘Pupcoin Bubble’ Deflates
There's no rush to cash out if you already own Shiba Inu, but start thinking about making your exit. If you don't own SHIB-USD yet? There's little reason to buy right now. More
Palantir Technologies Has More Catalysts Than Just Government Spending
Having reported solid revenue numbers for the third quarter, Palantir is ready to take over the commercial sector. PLTR stock is a buy. More
Could Floki Inu Be the Crypto That Ultimately Gets Me in the Game?
There’s an argument that Floki Inu has the utility necessary to send it to the cryptocurrency big leagues. If that’s the case, I’m in. More
